Re-Cognition Health

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease1 trial
• Migraine1 trial
• Mild cognitive impairment1 trial

Phase

• Phase 41 trial

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Novoic Limited1 trial
• Pfizer1 trial

Closed trials

• Completed

  Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

  NCT05217927· Phase 4· Pfizer· Source

• Terminated

  Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension

  NCT04846426· Novoic Limited· Source